.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Covington
Healthtrust
Farmers Insurance
AstraZeneca
Cipla
Baxter
Citi
Merck
Boehringer Ingelheim

Generated: November 21, 2017

DrugPatentWatch Database Preview

Bicalutamide - Generic Drug Details

« Back to Dashboard

What are the generic sources for bicalutamide and what is the scope of bicalutamide patent protection?

Bicalutamide
is the generic ingredient in two branded drugs marketed by Sun Pharma Global, Santos Biotech, Accord Hlthcare, Teva, Watson Labs Teva, Fresenius Kabi Oncol, Synthon Pharms, Apotex Inc, Sandoz, Mylan, Roxane, Zydus Pharms Usa Inc, Kudco Ireland, and Astrazeneca Pharms, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for bicalutamide. Twenty-one suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Synthon Pharms
BICALUTAMIDE
bicalutamide
TABLET;ORAL077973-001Jul 6, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
BICALUTAMIDE
bicalutamide
TABLET;ORAL079110-001Jul 6, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
BICALUTAMIDE
bicalutamide
TABLET;ORAL200274-001May 21, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
BICALUTAMIDE
bicalutamide
TABLET;ORAL078634-001Aug 28, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Kudco Ireland
BICALUTAMIDE
bicalutamide
TABLET;ORAL077995-001Jul 6, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
BICALUTAMIDE
bicalutamide
TABLET;ORAL079185-001Jul 6, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
BICALUTAMIDE
bicalutamide
TABLET;ORAL078917-001Jul 6, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
BICALUTAMIDE
bicalutamide
TABLET;ORAL076932-001Jul 6, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca Pharms
CASODEX
bicalutamide
TABLET;ORAL020498-001Oct 4, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
BICALUTAMIDE
bicalutamide
TABLET;ORAL079089-001Jul 6, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: bicalutamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms
CASODEX
bicalutamide
TABLET;ORAL020498-001Oct 4, 1995► Subscribe► Subscribe
Astrazeneca Pharms
CASODEX
bicalutamide
TABLET;ORAL020498-001Oct 4, 1995► Subscribe► Subscribe
Astrazeneca Pharms
CASODEX
bicalutamide
TABLET;ORAL020498-001Oct 4, 1995► Subscribe► Subscribe
Astrazeneca Pharms
CASODEX
bicalutamide
TABLET;ORAL020498-001Oct 4, 1995► Subscribe► Subscribe
Astrazeneca Pharms
CASODEX
bicalutamide
TABLET;ORAL020498-001Oct 4, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Harvard Business School
Queensland Health
Novartis
Cipla
Dow
McKesson
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot